Updated:
SemperVirens Venture Capital
SemperVirens Venture Capital backs AI-driven workforce startups, coupling $300M+ in raised capital with a go-to-market ecosystem of 8,000+ enterprise...
SemperVirens Venture Capital
SemperVirens Venture Capital organizes its investment thesis around a connected ecosystem designed to accelerate go-to-market for companies operating in complex, regulated markets. Its model pairs early- through growth-stage capital with practical distribution support: introductions to decision-makers, pricing and positioning guidance, and access to partner distribution channels that the firm claims have helped drive over 1,000 deals. The firm invests across three verticals it labels health, wealth, and work. Confirmed portfolio companies include virtual menopause clinic Midi Health, global employment platform Remote, fertility-benefits provider Carrot Fertility, mental-health platform Rula, healthcare-navigation company Rightway, recruiting platform Ashby, upskilling company Multiverse, entry-level healthcare training startup Stepful, SMB retirement provider Human Interest, and embedded-payroll infrastructure company Salsa. Geographically, the firm operates from offices in New York, White Plains, Los Altos, London, and Blagoevgrad. SemperVirens reports more than $300M raised from institutional, strategic, and impact-oriented limited partners, with capital deployed through two distinct investment vehicles organized by stage. The firm fields an advisory board that includes executives from global companies, and its internal metrics cite over 200 executive advisors and 50 sector experts. No recent operational event within the last 24 months was verifiable from public disclosures. Structurally, SemperVirens functions less as a passive venture investor and more as an active distribution partner, weaving a network of enterprise buyers explicitly into its value proposition. This hybrid of funder and market-access driver — documented on its own materials as 'ecosystem-driven venture capital' — departs from the standard GP playbook by making commercial introductions a formalized, scaled part of the investment product.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Additional offices
White Plains, NY · Los Altos, CA · London, UK · Blagoevgrad, Bulgaria
Sector focus
Frequently asked questions
How does SemperVirens source its investment opportunities?
SemperVirens describes itself as an ecosystem-driven venture capital firm. It sources through a proprietary network of over 8,000 enterprise buyers, 200 executive advisors, and 50 sector experts who provide warm introductions and market intelligence. The firm runs an accelerator program — a Spring 2026 cohort was recently announced — which serves as a top-of-funnel mechanism for early-stage relationships.
What type of capital does SemperVirens deploy?
The firm deploys stage-specific capital across two distinct investment vehicles. It supports companies from accelerator to growth funds, with more than $300M raised from institutional, strategic, and impact-oriented LPs. Investments span pre-seed through growth equity, though the firm does not publicly detail fund sizes or vintage-by-vintage breakdowns.
Which sectors does SemperVirens explicitly target?
SemperVirens organizes its practice around three domains: health (digital health, benefits, care delivery), wealth (fintech, retirement, embedded payroll), and work (HR tech, upskilling, recruiting). The firm invests primarily in AI-driven enterprise software startups that sell into complex buyer groups — employers, insurers, and HR organizations.
How does SemperVirens support portfolio companies beyond capital?
Beyond a check, SemperVirens provides a formalized go-to-market engine. Its team facilitates introductions to enterprise buyers (over 5,000 customer intros reported) and partner distribution channels (1,000+ deals driven). Advisors help with pricing, positioning, and early customer acquisition. The firm tracks $175M-plus in directly influenced ARR across its portfolio.
Does SemperVirens co-invest alongside other venture firms?
The firm's public materials do not detail a formal co-investment program. Its investment model emphasizes being an early partner — often starting at pre-seed — with a long-term, multi-stage commitment. Portfolio company syndicates are not disclosed, though the firm's ecosystem includes institutional LPs that may also invest directly in later rounds.
Who runs SemperVirens Venture Capital?
The firm's website highlights a team of investors, operators, and sector experts, but does not publicly name its general partners or investment committee. No LinkedIn page was located to supplement the leadership roster. Without named principals, the decision-making structure remains opaque.
What is the geographic focus of SemperVirens investments?
SemperVirens maintains offices in New York, White Plains, Los Altos, London, and Blagoevgrad, suggesting a transatlantic operating footprint. Its portfolio includes companies with global customer bases — Remote, for instance, handles international employment — but the firm does not publish a country-by-country investment allocation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: